TWI387454B - 治療胃腸道疾病之方法及組成物 - Google Patents

治療胃腸道疾病之方法及組成物 Download PDF

Info

Publication number
TWI387454B
TWI387454B TW094129818A TW94129818A TWI387454B TW I387454 B TWI387454 B TW I387454B TW 094129818 A TW094129818 A TW 094129818A TW 94129818 A TW94129818 A TW 94129818A TW I387454 B TWI387454 B TW I387454B
Authority
TW
Taiwan
Prior art keywords
composition
administered
treatment
constipation
compound
Prior art date
Application number
TW094129818A
Other languages
English (en)
Chinese (zh)
Other versions
TW200612901A (en
Inventor
上野隆司
Original Assignee
蘇坎波公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35229739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI387454(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 蘇坎波公司 filed Critical 蘇坎波公司
Publication of TW200612901A publication Critical patent/TW200612901A/zh
Application granted granted Critical
Publication of TWI387454B publication Critical patent/TWI387454B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
TW094129818A 2004-09-02 2005-08-31 治療胃腸道疾病之方法及組成物 TWI387454B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60652104P 2004-09-02 2004-09-02
US66631705P 2005-03-30 2005-03-30
US66659305P 2005-03-31 2005-03-31

Publications (2)

Publication Number Publication Date
TW200612901A TW200612901A (en) 2006-05-01
TWI387454B true TWI387454B (zh) 2013-03-01

Family

ID=35229739

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094129818A TWI387454B (zh) 2004-09-02 2005-08-31 治療胃腸道疾病之方法及組成物

Country Status (16)

Country Link
US (2) US8748481B2 (cg-RX-API-DMAC7.html)
EP (1) EP1791545B1 (cg-RX-API-DMAC7.html)
JP (4) JP2008511541A (cg-RX-API-DMAC7.html)
KR (4) KR20070048221A (cg-RX-API-DMAC7.html)
CN (1) CN102885821A (cg-RX-API-DMAC7.html)
AR (1) AR050626A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005278323B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514891A (cg-RX-API-DMAC7.html)
CA (1) CA2577284A1 (cg-RX-API-DMAC7.html)
ES (1) ES2603381T3 (cg-RX-API-DMAC7.html)
IL (1) IL181332A (cg-RX-API-DMAC7.html)
MX (1) MX2007002602A (cg-RX-API-DMAC7.html)
NO (1) NO340989B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ553434A (cg-RX-API-DMAC7.html)
TW (1) TWI387454B (cg-RX-API-DMAC7.html)
WO (1) WO2006025599A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1562604E (pt) * 2002-10-23 2012-04-09 Sucampo Ag Compostos de prostaglandina para o tratamento de obesidade
EP1641462B1 (en) * 2003-07-03 2010-11-24 Sucampo AG Enteric coated composition comprising prostaglandin analogs as chloride channel opener
EP1984027B1 (en) 2006-01-24 2015-12-30 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
CA2870252A1 (en) * 2012-04-23 2013-10-31 Sucampo Ag Method for treating irritable bowel syndrome with diarrhea
AU2014213251B2 (en) * 2013-02-04 2017-07-20 Taisho Pharmaceutical Co., Ltd. Prophylactic or therapeutic drug for constipation
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5380709A (en) 1987-01-28 1995-01-10 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
JP4332316B2 (ja) 1999-10-15 2009-09-16 スキャンポ・アーゲー 二環式化合物組成物およびその安定化方法
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
PT1389116E (pt) 2001-05-18 2008-04-11 Sucampo Ag Composição de indução catártica
BR0212233A (pt) * 2001-08-31 2004-10-05 Sucampo Ag Abridor de canal de cloreto
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
KR101164838B1 (ko) * 2002-12-27 2012-07-11 수캄포 아게 복부 불쾌감 치료용 프로스타글랜딘의 유도체
EP1641462B1 (en) 2003-07-03 2010-11-24 Sucampo AG Enteric coated composition comprising prostaglandin analogs as chloride channel opener

Also Published As

Publication number Publication date
CN102885821A (zh) 2013-01-23
ES2603381T3 (es) 2017-02-27
US8748481B2 (en) 2014-06-10
AR050626A1 (es) 2006-11-08
IL181332A0 (en) 2007-07-04
NZ553434A (en) 2010-01-29
NO340989B1 (no) 2017-07-31
JP6408426B2 (ja) 2018-10-17
KR20070048221A (ko) 2007-05-08
US20060063830A1 (en) 2006-03-23
AU2005278323A1 (en) 2006-03-09
JP2008511541A (ja) 2008-04-17
BRPI0514891A (pt) 2008-06-24
KR20170003712A (ko) 2017-01-09
KR20180033310A (ko) 2018-04-02
EP1791545B1 (en) 2016-08-31
WO2006025599A1 (en) 2006-03-09
MX2007002602A (es) 2007-04-25
JP2018150354A (ja) 2018-09-27
JP2015166377A (ja) 2015-09-24
AU2005278323B2 (en) 2011-03-17
NO20071704L (no) 2007-05-31
EP1791545A1 (en) 2007-06-06
JP2013049688A (ja) 2013-03-14
US20140315994A1 (en) 2014-10-23
CA2577284A1 (en) 2006-03-09
IL181332A (en) 2015-09-24
KR20140019006A (ko) 2014-02-13
TW200612901A (en) 2006-05-01

Similar Documents

Publication Publication Date Title
JP6408426B2 (ja) 胃腸障害処置用プロスタグランジン誘導体
US20100298424A1 (en) Method for treating abdominal discomfort
JP2011201905A (ja) 便秘の処置用のプロスタグランジンアナログを含む用量単位
US20090012165A1 (en) Pharmaceutical combination of nsaid and prostaglandin compound
JP5427029B2 (ja) 消化管の重炭酸分泌を促進するための方法および組成物
US10561649B2 (en) Pharmaceutical combination of opioid and prostaglandin compound
RU2392941C2 (ru) Производные простагландинов для лечения желудочно-кишечного нарушения
TWI594751B (zh) 治療帶有腹瀉之腸躁症之方法

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent